Massimo Gion

411 total citations
24 papers, 303 citations indexed

About

Massimo Gion is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Massimo Gion has authored 24 papers receiving a total of 303 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 6 papers in Molecular Biology. Recurrent topics in Massimo Gion's work include Prostate Cancer Diagnosis and Treatment (10 papers), Prostate Cancer Treatment and Research (9 papers) and Lung Cancer Treatments and Mutations (4 papers). Massimo Gion is often cited by papers focused on Prostate Cancer Diagnosis and Treatment (10 papers), Prostate Cancer Treatment and Research (9 papers) and Lung Cancer Treatments and Mutations (4 papers). Massimo Gion collaborates with scholars based in Italy, Nepal and United Kingdom. Massimo Gion's co-authors include Ruggero Dittadi, R. Mione, Antonette E. Leon, Manfred Schmitt, Fred C.G.J. Sweep, George G. Klee, Alessandra Rosalba Brazzale, Angelo Paradiso, A. Fandella and Herbert A. Fritsche and has published in prestigious journals such as British Journal of Cancer, Clinical Chemistry and European Urology.

In The Last Decade

Massimo Gion

24 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Massimo Gion Italy 11 153 105 101 52 36 24 303
Andrew Erickson Finland 13 254 1.7× 122 1.2× 116 1.1× 91 1.8× 45 1.3× 40 417
Salma Alam United Kingdom 10 160 1.0× 143 1.4× 91 0.9× 86 1.7× 10 0.3× 14 332
Raja Mudad United States 15 133 0.9× 174 1.7× 44 0.4× 46 0.9× 21 0.6× 35 435
Axel Glaessgen Sweden 8 347 2.3× 86 0.8× 109 1.1× 55 1.1× 94 2.6× 12 470
G. Atalay Belgium 7 72 0.5× 182 1.7× 63 0.6× 82 1.6× 50 1.4× 12 317
W. P. Peelen Netherlands 9 212 1.4× 62 0.6× 150 1.5× 85 1.6× 29 0.8× 14 400
Joachim Müller Switzerland 12 187 1.2× 159 1.5× 85 0.8× 42 0.8× 130 3.6× 23 393
Masatoshi Muramoto Japan 8 419 2.7× 80 0.8× 120 1.2× 93 1.8× 59 1.6× 15 558
Gui-Ming Zhang China 12 157 1.0× 144 1.4× 132 1.3× 118 2.3× 10 0.3× 21 361
Kojiro Tashiro Japan 9 191 1.2× 129 1.2× 49 0.5× 44 0.8× 32 0.9× 56 316

Countries citing papers authored by Massimo Gion

Since Specialization
Citations

This map shows the geographic impact of Massimo Gion's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Massimo Gion with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Massimo Gion more than expected).

Fields of papers citing papers by Massimo Gion

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Massimo Gion. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Massimo Gion. The network helps show where Massimo Gion may publish in the future.

Co-authorship network of co-authors of Massimo Gion

This figure shows the co-authorship network connecting the top 25 collaborators of Massimo Gion. A scholar is included among the top collaborators of Massimo Gion based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Massimo Gion. Massimo Gion is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Parekh, Mohit, et al.. (2013). Evaluation of the HB&L System for the Microbiological Screening of Storage Medium for Organ-Cultured Corneas. Journal of Ophthalmology. 2013. 1–5. 5 indexed citations
3.
Paradiso, Angelo, Anita Mangia, Claudio Orlando, et al.. (2009). The Integrated Oncology Program of the Italian Ministry of Health.Analytical and clinical validation of new biomarkers for early diagnosis: network,resources, methodology, quality control, and data analysis. The International Journal of Biological Markers. 24(3). 119–129. 5 indexed citations
4.
Verderio, Paolo, Ruggero Dittadi, Ettore Marubini, et al.. (2007). An Italian program of External Quality Control for chromogranin A (CgA) assay: performance evaluation of CgA determination. Clinical Chemistry and Laboratory Medicine (CCLM). 45(9). 1244–50. 19 indexed citations
5.
Dittadi, Ruggero, R. Franceschini, Antonio Fortunato, et al.. (2007). Interchangeability and diagnostic accuracy of two assays for total and free prostate-specific antigen: two not always related items. The International Journal of Biological Markers. 22(2). 154–158. 5 indexed citations
6.
Dittadi, Ruggero, R. Franceschini, Antonio Fortunato, et al.. (2007). Interchangeability and Diagnostic Accuracy of Two Assays for Total and Free Prostate-Specific Antigen: Two not Always Related Items. The International Journal of Biological Markers. 22(2). 154–158. 6 indexed citations
7.
Bertaccini, Alessandro, A. Fandella, Tommaso Prayer‐Galetti, et al.. (2007). Systematic development of clinical practice guidelines for prostate biopsies: a 3-year Italian project.. PubMed. 27(1B). 659–66. 17 indexed citations
8.
Fra, J., Antonio López–Pousa, Marta Sierra, et al.. (2006). Phase II study with the combination of gemcitabine and DTIC in patients with advanced soft tissue sarcomas. Cancer Chemotherapy and Pharmacology. 59(2). 251–259. 25 indexed citations
9.
Paradiso, Angelo, Paolo Verderio, Sara Pizzamiglio, et al.. (2005). An Italian Program of External Quality Control for Chromogranin A (CgA) Assay: State of the Art of Cga Measurement. The International Journal of Biological Markers. 20(4). 264–268. 3 indexed citations
10.
Daidone, Maria Grazia, Angelo Paradiso, Massimo Gion, et al.. (2004). Biomolecular features of clinical relevance in breast cancer. European Journal of Nuclear Medicine and Molecular Imaging. 31(0). S3–S14. 11 indexed citations
11.
Sweep, Fred C.G.J., Herbert A. Fritsche, Massimo Gion, George G. Klee, & Manfred Schmitt. (2003). Considerations on development, validation, application, and quality control of immuno(metric) biomarker assays in clinical cancer research: An EORTC-NCI working group report. International Journal of Oncology. 23(6). 1715–26. 25 indexed citations
12.
Gion, Massimo, R. Mione, Filiberto Zattoni, et al.. (2000). Clinical Evaluation of Percent Free Prostate–Specific Antigen Using the AxSYM System in the Best Analytical Scenario. European Urology. 37(4). 460–469. 2 indexed citations
13.
Gion, Massimo, R. Mione, Antonette E. Leon, & Ruggero Dittadi. (1999). Comparison of the diagnostic accuracy of CA27.29 and CA15.3 in primary breast cancer.. PubMed. 45(5). 630–7. 68 indexed citations
14.
Gion, Massimo, R. Mione, Filiberto Zattoni, et al.. (1998). Percent free prostate-specific antigen in assessing the probability of prostate cancer under optimal analytical conditions. Clinical Chemistry. 44(12). 2462–2470. 13 indexed citations
15.
Gion, Massimo, R. Mione, Filiberto Zattoni, et al.. (1998). Percent free prostate-specific antigen in assessing the probability of prostate cancer under optimal analytical conditions.. PubMed. 44(12). 2462–70. 14 indexed citations
16.
Mione, R., Giuseppe Aimo, Emilio Bombardieri, et al.. (1996). Preliminary Results of Clinical Evaluation of the Free/Total Prostate-Specific Antigen Ratio in a Multicentric Study. Tumori Journal. 82(6). 543–549. 4 indexed citations
17.
Dittadi, Ruggero, Alberto Ruol, Massimo Gion, et al.. (1995). EPIDERMAL GROWTH-FACTOR RECEPTORS AND ERBB2 PROTEIN EXPRESSION IN ESOPHAGEAL CANCER AND NORMAL MUCOSA. Oncology Reports. 2(3). 381–5. 1 indexed citations
19.
Dittadi, Ruggero, Massimo Gion, Alessandra Rosalba Brazzale, et al.. (1994). Comparison between western blotting, immunohistochemical and ELISA assay for p185neu quantitation in breast cancer specimens.. PubMed. 13(5C). 1821–4. 21 indexed citations
20.
Dittadi, Ruggero, et al.. (1991). Epidermal growth factor receptor in lung malignancies. Comparison between cancer and normal tissue. British Journal of Cancer. 64(4). 741–744. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026